Quest Diagnostics to Speak at the Morgan Stanley Global Healthcare Conference
MADISON, N.J., Sept. 6, 2013 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the Morgan Stanley Global Healthcare Conference in New York City. Steve Rusckowski, the company's President and CEO, will discuss the company's vision, goals and five point strategy. The presentation is scheduled for Monday, September 9, 2013 at 10:00 a.m. Eastern Time.
The presentation will be webcast live during the conference and will be available to registered investors on the following site: http://cc.talkpoint.com/morg007/090913a_mc/?entity=135_SHNB4RR and to the public on www.QuestDiagnostics.com/investor. In addition, the archived webcast will be available one hour after the conclusion of the live event and will remain available until October 9, 2013.
Quest Diagnostics is the world's leading provider of diagnostic information services that patients and doctors need to make better healthcare decisions. The company offers the broadest access to diagnostic testing services through its network of laboratories and patient service centers, and provides interpretive consultation through its extensive medical and scientific staff. Quest Diagnostics is a pioneer in developing innovative diagnostic tests and advanced healthcare information technology solutions that help improve patient care. Additional company information is available at QuestDiagnostics.com.
Dan Haemmerle (Investors): 973-520-2900
Wendy Bost (Media 973-520-2800
SOURCE Quest Diagnostics